Drug Discovery Services Market By Type (Medicinal Chemistry Services, Biology Services, Pharmacokinetics and Drug Metabolism), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology, Neurological Disorder, Respiratory Disease, Diabetes, Cardiovascular Disease), By Regions (North America, Europe, Asia Pacific, Rest of the World) – Global Forecast up to 2025

Global Drug Discovery Services Market By Type (Medicinal Chemistry Services, Biology Services, Pharmacokinetics and Drug Metabolism), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology, Neurological Disorder, Respiratory Disease, Diabetes, Cardiovascular Disease), By Regions (North America, Europe, Asia Pacific, Rest of the World) Global Forecast up to 2025

This market research report includes a detailed segmentation of the global drug discovery services market by type (medicinal chemistry services, biology services, and pharmacokinetics and drug metabolism), by drug type (small molecules and biologics), by therapeutic area (oncology, neurological disorder, respiratory disease, diabetes, cardiovascular disease, and others), and by regions (North America, Europe, Asia Pacific, and Rest of the World).

Overview of the Global Drug Discovery Services Market Research:

Infoholics market research report predicts that the global drug discovery services market will grow at a CAGR of 11.7% during the forecast period 20192025. Drug discovery refers to the process of identifying potential new medicines, and it involves a wide range of scientific disciplines, including biology, chemistry, and pharmacology. The process of drug discovery involves various methods such as identification of target molecule, candidate drug identification, characterization, screening, and assays for therapeutic efficacy. Once a candidate compound has shown its therapeutic value in these tests, it will begin the process of drug development prior to clinical trials. In recent years, there is a lot of interest in biologics-based drug discovery. Biologics drug discovery includes developing new novel antibodies, recombinant proteins, hormones, vaccines, cell therapy, and gene therapy for treating cancer, neurological disorders, cardiovascular disorders, and many others.
The upsurge in the externalization of R&D activities, rising expenditure on R&D, expiration of patents boosting the demand for drug discovery, and introduction of advanced technologies are few of the factors driving the growth of the drug discovery services market.
Increasing patient base for various chronic & lifestyle diseases and growing advancements in innovative technologies will enhance the revenue of the drug discovery services market in the next five years.

The industry generates the majority of the revenue from the key players operating in this field; few of them include Charles River Laboratories, Evotec SE, GVK Biosciences, Albany Molecular Research Inc., Domainex Ltd., Genscript Biotech Corporation, Syngene International Ltd., Eurofins Scientific SE, and Laboratory Corporation of America Holdings.

According to the analysis, North America accounted for the largest share of the global drug discovery services market in 2018 and will retain a high position during the forecast period. North America is followed by Europe, with a share of more than 25% of the global market in 2018.

By Type:
Medicinal Chemistry Services
Biology Services
Pharmacokinetics and Drug Metabolism

In 2018, the medicinal chemistry services segment accounted for the largest share and is expected to grow at a high-double-digit CAGR during the forecast period. Increasing tendency of pharma companies to externalize discovery and development services, increasing number of drug discovery and development activities, and growing R&D expenditure are the key factors driving the growth of the medicinal chemistry services segment. The biology services segment is projected to grow at a high CAGR during the forecast period 20192025.

By Drug Type:
Small Molecules
Biologics

The small molecules segment occupied a significant share in 2018, and biologics is expected to grow at a high CAGR during the forecast period 20192025. The increasing use of small molecules drugs to treat chronic disease is leading to increased demand for these drugs.

By Therapeutic Area:
Neurological Disorder
Diabetes
Oncology
Respiratory Disease
Cardiovascular Disease
Others

Based on therapeutic areas, oncology dominated the market in 2018 and is expected to maintain its position throughout the forecast period. The high demand for cancer therapies due to the increasing number of cancer cases across the globe makes the segment a dominant shareholder in the coming years.

By Regions:
North America
Europe
Asia Pacific
Rest of the World

Based on geography, North America dominated the market in 2018 with a market share of over 40% and is expected to maintain this position throughout the forecast period. Increasing demand for personalized medicine, well-established healthcare sector, rising incidence of chronic disease, availability of advanced technologies, high healthcare expenditure, and rising growth of the biopharmaceutical market are few of the factors that make North America a dominant shareholder in the global drug discovery services market. Asia Pacific is projected to grow at the fastest rate during the forecast period 20192025.

Global Drug Discovery Services Market Research Competitive Analysis: The market is growing at a steady rate with a CAGR of 11.7% during the forecast period 20192025. The increasing burden of disease and the need for new therapeutic drugs have led to an increase in collaboration between companies for drug discovery services. For instance, in September 2019, German-based Evotec entered into a multi-year drug discovery collaboration agreement with Japanese pharma company Takeda Pharmaceutical Company Limited. According to the collaboration terms, Evotec will leverage its technology platform to establish five drug discovery programs in the field of oncology, neuroscience, gastroenterology, and rare diseases, which Takeda will advance into clinical development.
East Midlands life sciences researchers and GSK entered into a strategic research collaboration for lung disease in February 2018, and the partnership is expected to accelerate discovery and development of innovative treatments for COPD and related airway diseases.

Key Vendors:
Charles River Laboratories
GVK Biosciences
Evotec SE
Albany Molecular Research Inc.
Domainex Ltd.
Genscript Biotech Corporation
Laboratory Corporation of America Holdings (LabCorp)
Syngene International Ltd.
Eurofins Scientific SE
Pharmaceutical Product Development
Jubilant Life Sciences
WuXi AppTec Co., Ltd.

Key Competitive Facts:
In 2019, Lundbeck acquired Abide Therapeutics for $250 million and takes control of Abides drug discovery platform focused on serine hydrolases, which is a diverse enzyme class that accounts for roughly 1% of all proteins in mammals.
In May 2019, Amgen acquired Nuevolution for $167 million following their three-year collaboration, which is expected to boost the Amgens drug discovery platform.
Benefits The report provides complete details about the sub-segment of the global drug discovery services market. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, and government initiatives toward the drug discovery services segment in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Takeaways:
Understanding the potential market opportunity with precise market size and forecast data.
Detailed market analysis focusing on the growth of the drug discovery services industry.
Factors influencing the growth of the drug discovery services market.
In-depth competitive analysis of dominant and pure-play vendors.
Prediction analysis of the drug discovery services market in both developed and developing regions.
Key insights related to major segments of the drug discovery services market.
Latest market trend analysis impacting the buying behavior of the consumers.




1Industry Outlook7
1.1Industry Overview7
1.1.1Overview7
1.1.2Global Driver for Pharmaceutical Demand:8
1.1.3R&D pipeline in pharmaceutical industry8
1.1.4Top pharma drugs by sales ($Million)9
1.2Industry Trends10
1.3Total Addressable Market10
2Report Outline12
2.1Report Scope12
2.2Report Summary12
2.3Research Methodology13
2.4Report Assumptions14
3Market Snapshot15
3.1Market Definition Infoholic Research15
3.2Need for discovery and development services15
3.3Segmented Addressable Market (SAM)15
3.4Trends of the drug discovery services Market17
3.5Related Markets18
3.5.1Pharmaceutical Contract Manufacturing Organization18
3.5.2Pharma contract research organization19
4Market Outlook20
4.1Market Segmentation20
4.2PEST Analysis21
4.3Porter 5 (Five) Forces22
5Market Characteristics23
5.1DRO Market Dynamics23
5.1.1Drivers24
5.1.1.1Upsurge in outsourcing of R&D activities24
5.1.1.2Rising expenditure on research and development24
5.1.2Restraints25
5.1.2.1High cost for discovery and development of the drug25
5.1.2.2Strict regulations governing the drug development and ethical issues related to animal studies25
5.1.3Opportunities26
5.1.3.1Advent of innovative technology26
5.1.3.2Expiration of patent boosts demand for drug discovery26
5.2DRO Impact Analysis27
5.3Key Stakeholders28
6Type: Market Size and Analysis29
6.1Overview29
6.2Medicinal chemistry services31
6.3Biology Services32
6.4Pharmacokinetics and drug metabolism33
7Drug Type: Market Size and Analysis34
7.1Overview34
7.2Small molecules36
7.3Biologics37
8Therapeutic area: Market Size and Analysis39
8.1Overview39
8.2Oncology39
8.3Neurological disorder40
8.4Respiratory disease40
8.5Diabetes40
8.6Cardiovascular disease40
8.7Others41
9Regions: Market Size and Analysis42
9.1Overview42
9.2North America43
9.3Europe45
9.4Asia Pacific46
9.4.1Overview46
9.5Rest of the World47
10Competitive Landscape49
10.1Overview49
11Vendors Profile52
11.1Charles River Laboratories52
11.2GVK Biosciences55
11.3Evotec SE58
11.4Albany Molecular Research Inc. (AMRI)62
11.5Domainex Ltd.63
11.6GenScript Biotech65
12Companies to Watch For69
12.1Laboratory Corporation of America Holdings (LabCorp)69
12.2Syngene International Ltd71
12.3Eurofin Scientific SE73
12.4Pharmaceutical product Development76
12.5Jubilant Life Sciences77
12.6WuXi AppTec Co., Ltd.78
Annexure81
Abbreviations81
?

List Of Tables



TABLE 1GLOBAL DRUG DISCOVERY SERVICES MARKET REVENUE, BY REGIONS, 20182025 ($MILLION)44
TABLE 2OTHER VENDORS IN THE DRUG DISCOVERY SERVICES MARKET52
TABLE 3BUSINESS SUMMARY: CHARLES RIVER LABORATORIES54
TABLE 4BUSINESS SUMMARY: GVK BIOSCIENCES57
TABLE 5BUSINESS SUMMARY: EVOTEC SE60
TABLE 6BUSINESS SUMMARY: ALBANY MOLECULAR RESEARCH INC.63
TABLE 7BUSINESS SUMMARY: DOMAINEX LTD.65
TABLE 8BUSINESS SUMMARY: GENSCRIPT BIOTECH67
TABLE 9BUSINESS SUMMARY: LABORATORY CORPORATION OF AMERICA HOLDINGS71
TABLE 10BUSINESS SUMMARY: SYNGENE INTERNATIONAL LTD72
TABLE 11BUSINESS SUMMARY: EUROFIN SCIENTIFIC74
TABLE 12BUSINESS SUMMARY: PHARMACEUTICAL PRODUCT DEVELOPMENT77
TABLE 13BUSINESS SUMMARY: JUBILANT LIFE SCIENCES78
TABLE 14BUSINESS SUMMARY: WUXI APPTEC CO., LTD79

Drug Discovery Services Market By Type (Medicinal Chemistry Services, Biology Services, Pharmacokinetics and Drug Metabolism), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology, Neurological Disorder, Respiratory Disease, Diabetes, Cardiovascular Disease), By Regions (North America, Europe, Asia Pacific, Rest of the World) – Global Forecast up to 2025

Global Drug Discovery Services Market By Type (Medicinal Chemistry Services, Biology Services, Pharmacokinetics and Drug Metabolism), By Drug Type (Small Molecules, Biologics), By Therapeutic Area (Oncology, Neurological Disorder, Respiratory Disease,

USD 2750 View Report

Global Fragment Based Drug Discovery Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Fragment Based Drug Discovery is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by

USD 4000 View Report

Global Fragment Based Drug Discovery Market Report 2019 - Market Size, Share, Price, Trend and Forecast

The global market size of Fragment Based Drug Discovery is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by

USD 4000 View Report

Asia Pacific Fragment Based Drug Discovery Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The Asia Pacific Fragment Based Drug Discovery market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available